## Core Concept
The question pertains to the mechanism by which loop diuretics and thiazides cause **hypokalemia**, a condition characterized by lower than normal potassium levels in the blood. Both classes of diuretics act on different parts of the nephron but share a common side effect of promoting potassium loss.

## Why the Correct Answer is Right
The correct answer, **. Increased potassium secretion in the collecting ducts**, is accurate because both loop diuretics and thiazides increase the delivery of sodium to the collecting ducts. In the collecting ducts, sodium is reabsorbed in exchange for potassium ions (secreted into the lumen) through the **sodium-potassium pump** and **aldosterone-sensitive sodium channels**. The increased sodium delivery enhances sodium reabsorption, which in turn increases potassium secretion. This results in increased potassium loss in the urine and can lead to **hypokalemia**.

## Why Each Wrong Option is Incorrect
- **Option A:** Decreased potassium reabsorption in the proximal convoluted tubule. While it's true that diuretics increase sodium delivery to the distal parts of the nephron, the primary issue isn't decreased potassium reabsorption in the proximal convoluted tubule but rather increased potassium secretion in the collecting ducts.
- **Option B:** Increased potassium reabsorption in the loop of Henle. This option is incorrect because the mechanism of hypokalemia doesn't primarily involve increased potassium reabsorption in the loop of Henle; instead, it's about increased potassium secretion in the collecting ducts.
- **Option D:** Decreased aldosterone levels. This option is incorrect because both loop diuretics and thiazides can lead to increased aldosterone levels (as part of the renin-angiotensin-aldosterone system response to volume depletion), which then promotes potassium secretion.

## Clinical Pearl / High-Yield Fact
A key clinical point to remember is that **potassium-sparing diuretics**, such as spironolactone (an aldosterone antagonist) or amiloride (a direct inhibitor of sodium channels), can be used to counteract the hypokalemic effect of loop and thiazide diuretics. This is especially important in patients at high risk of complications from hypokalemia, such as those with heart failure or on digoxin.

## Correct Answer: . Increased potassium secretion in the collecting ducts